Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

Welcome to this special segment of ES Quick Bits. While the core of our program is designed to sharpen clinical and pathology workflows, medicine ultimately achieves its highest purpose when it effectively serves the person sitting across from us in the exam room. For the next 10 minutes, we're stepping away from the data to look directly at real world patient and advocacy landscape. Before we begin, please note this medical education activity is supported by an educational grant from Ibsen. Joining us today to ground our perspective is Natasha Serrano, the board vice president of the Sarcoma Alliance. Natasha, thank you so much for being with us today to share your thoughts. Thank you so much for having me. It's uh an honor to be with you. Um, I'm excited to do this because I bring three very distinct perspectives to our conversation today. Not only am I a member of the Sarcoma Alliance where I currently serve as vice president, but in my professional life, I also work in patient engagement and advocacy. Um, but most important is I'm also here as the mother of a child who has been diagnosed with epithelioid sarcoma. So this really shows me. Um, a lot about the, the difference that multidisciplinary care can make and strong patient advocacy, of course. So I'm grateful for this opportunity to share these perspectives with you, and we're incredibly grateful for your time on our podcast today. Data shows that epithelioid sarcoma is so rare and often mimics entirely benign conditions. Natasha, from your perspective at the Sarcoma Alliance, what are the most significant emotional and logistical hurdles patients face during this prolonged period of clinical uncertainty? And how does a delayed diagnosis alter their relationship with the healthcare system? Yeah, that's a really, really important question and one I'm very happy to address. One thing I've learned both through my own family's journey and through the Sarcoma Alliance is that uncertainty can be just as overwhelming as the diagnosis itself. And so before families even hear the words epithelioid sarcoma, they're often navigating weeks or months, maybe years of unanswered questions. All while they're trying to balance their normal world, their work, their school, um, and then insurance authorizations and imaging and biopsies, referrals, and then the financial impact of it all starts showing up in their mailbox. Long diagnostic journeys can take a really heavy emotional toll. Patients become frustrated, scared, sometimes emotionally exhausted because they begin to wonder if they're being heard by their physicians, and they ask themselves why the experts can't understand. Doubt in the system begins to creep in, and it's not that they lose trust with their providers, it's that uncertainty itself begins to erode confidence. At the root of all of this though, is really fear and anxiety, and they're trying to hold themselves together while maintaining a sense of normalcy with their families. So, unfortunately, they begin to wonder if they themselves are overreacting. They begin to question themselves and what they perceive, and it, it's a very slippery slope from there. So what restores that confidence is partnership. In fact, it's really important to know, uh, that patients don't expect every doctor to know all of the answers. Um, they know that doctors are human. They know that sometimes they're not going to have all the information at their fingertips, but what they're hoping for. Is that their doctor will stand in the gap with them and say, I'm not sure what's going on, but we're going to figure this out together. One of the things I really appreciate about sarcoma specialists is their willingness to work in this multidisciplinary format across disciplines. And when a patient reaches that multidisciplinary sarcoma team, families finally feel that everyone is working together toward one goal. It starts to repair the loss of confidence that a long diagnostic journey creates, and it really begins to restore trust. To that end, the most important message that Sarcoma Alliance puts forward is that when there's a suspicion of sarcoma, early referral to a sarcoma center is critical. It's not because community physicians aren't excellent, but it's because rare diseases deserve rare disease expertise. And of course, an accurate diagnosis is the foundation of an optimal treatment plan. Hearing you describe that experience really underscores why diagnostic vigilance is so vital. As we know, breaking through the initial diagnostic barrier is just the first hurdle, and once a patient finally has answers, they're immediately thrown into a completely new wave of clinical uncertainty. When a patient is sitting across from their oncologist discussing these statistics and treatment pathways, what matters most to them beyond survival data and how can providers better weigh daily quality of life factors in these conversations? I mean, of course, survival matters and families cling to that hard data that their providers share with them. It's an anchor to their world. It's the linchpin to how they will be navigating their new future. Um, for my own family, we appreciated the data because it helped us understand the disease, um, but we've lived the diagnosis through everyday life. My own child was diagnosed with epithelioid sarcoma at age 8. So for us, we immediately began to focus on things like Is he going to lose a limb? How will this impact his ability to make friends? How can I explain cancer to an eight year old child? For adults with epithelioid sarcoma, they're saddled with how their diagnosis and treatment will impact if they'll ever be able to work again, or how their lifestyle will have to change, or who they're going to be able to rely on through the dark moments that they're going to experience. So when providers understand what matters most to that individual, treatment discussions really become truly patient centered. Looking back, I don't remember every statistic we were given, but I do remember the clinicians who helped us feel that we weren't facing those decisions alone. That's a powerful reminder that to a patient, quality of life is life. It's easy for clinicians to look at the progression charts. The patients are looking at their daily realities. Beyond the medical management itself, there's an entire infrastructure of a person's life that gets completely disrupted by a sarcoma diagnosis. What do you see as the most critical non-clinical gaps, whether they be financial, psychological, or navigational, that patients encounter during their care journey? And how does the advocacy landscape step in to fill those voids? I'm really excited that you asked me that question, um. I can say that the thing that surprised me the most is how much a rare disease journey actually happens outside of the hospital or the clinic. I turned to our care coordinator frequently in the first few weeks because I needed answers and needed someone to go to. Um, but I recognized very quickly that her ability to help with what I needed was very limited to the clinical setting, and all of a sudden I found myself becoming a project manager. So while working full time myself, I found myself having to also do all of the other things in the gap coordinating appointments, collecting records and sending them, navigating insurance, arranging travel, managing finances, explaining everything to both my employer and his school, trying to support my other child and my spouse all at the same time, and all of this was being done while I was desperately trying to educate myself on something that I had never even heard of. That's where organizations like the Sarcoma Alliance become so important because we help guide patients with any sarcoma type to seek a second opinion from a sarcoma specialist. The second opinion isn't because anyone is questioning their physician, it's just simply good medicine for sarcoma diseases. Widening the care routine to include a sarcoma specialist provides reassurance to families who are fearful of the unknown, and it also provides additional medical insights that the care team can leverage. Sarcoma Alliance provides a financial grant to help with the costs associated with travel and specialist coverage, and we also connect patients with peer support and provide navigation, so families don't feel like they're carrying the entire journey by themselves. One of the hardest parts of having a rare cancer like this is believing you're the only person going through it. I went 4 years before I found another person with a sarcoma, and it wasn't epithelioid sarcoma. Sarcoma Alliance and other sarcoma advocacy organizations ultimately want every family to know that they're not alone. It's clear from what you're describing that standard clinical practice simply isn't built to shoulder all of these non-clinical burdens and organizations like the Sarcoma Alliance are there to support patients. This educational initiative is.